About the journal
Infection and Drug Resistance is an open-access journal published by Dove Medical Press in United Kingdom, publishing in english. It is listed in DOAJ and PUBMED according to the sources read. Declared publication charge: 4,320 USD. Declared review time at DOAJ: 16 weeks. Facts are reproduced as recorded at their sources with their capture dates; PublishLens indicators are available after sign-in.
Basic facts
- Publisher
- Dove Medical Press
- ISSN
- 1178-6973
- Country
- United Kingdom
- Languages
- english
- Access
- Open access
- Declared publication charge
- 4,320 USD
- Articles in DOAJ
- 4809
- Declared review time
- 16 weeks
- Declared peer-review model
- other
- Official website
- https://www.dovepress.com/infection-and-drug-resistance-journal
Index listings
- DOAJ · 2009-04-15
- PUBMED · 2013-09-18
- Indexing
- DOAJ · PUBMED
- APC
- 4,320 USD
- Declared review time (DOAJ)
- 16 weeks — journal-declared only (not measured)
- Activity (OpenAlex)
- Active — latest works 2026
- PublishLens list status
- Shown after sign-in
- Counts for promotion at your university?
- Choose your university and rank below ↓
Methodology signals (dated facts from their sources)
Details of the evaluation under the published methodology are shown to signed-in users (free).
Create a free account to view the evaluationJournal profile
Descriptive metadata from public sources (DOAJ, OpenAlex, PubMed) as of the capture date shown — contains no assessment or judgment.
Articles in DOAJ
4809
Most recent article
last month
Average review time (journal-declared via DOAJ)
16weeks
Works in OpenAlex
4953
Last recorded publication year
2026
h-index
94
i10-index
2071
From OpenAlex open data (CC0).
Editorial & policy13
- Last DOAJ review date
- 2026-04-27
- Added to DOAJ
- 2009-04-15
- Declared plagiarism screening
- Declared
- Other fees beyond APC
- No
- Declared digital preservation
- CLOCKSSPMC
- Observed digital preservation (Keepers registry)— snapshot 2026-10-05
- CLOCKSS
- Editorial board
- Official page ↗
- Norwegian register (HK-dir)— 2026
- Level 1 — approved scholarly channel
- Open references deposited at Crossref
- 83%
- ORCID iDs in current deposits
- 70%
- Enrolled in Crossref Similarity Check
- ✓
- Deposits licence metadata at Crossref
- ✓
- APC waiver policy
- View policy
- Peer-review policy
- View policy
Identity & continuity2
- Source type
- journal
- NLM unique ID (PubMed)
- 101550216
Classification2
Subjects (DOAJ)
LCC codes
Subject areas
- Antibiotic Resistance in Bacteria
- Antibiotic Resistance in Bacteria
- Antibiotic Resistance in Bacteria
- Antibiotic Use and Resistance
- Antimicrobial Resistance in Staphylococcus
- Tuberculosis Research and Epidemiology
- Tuberculosis Research and Epidemiology
- Bacterial Identification and Susceptibility Testing
Show all subjects (75)
- Bacterial Identification and Susceptibility Testing
- Tuberculosis Research and Epidemiology
- Infectious Diseases and Tuberculosis
- Bacterial Identification and Susceptibility Testing
- Antibiotic Use and Resistance
- Antibiotic Use and Resistance
- Infections and bacterial resistance
- Antibiotics Pharmacokinetics and Efficacy
- Antibiotics Pharmacokinetics and Efficacy
- Nosocomial Infections in ICU
- Antifungal resistance and susceptibility
- Nosocomial Infections in ICU
- Antimicrobial Resistance in Staphylococcus
- Antimicrobial Resistance in Staphylococcus
- Pneumonia and Respiratory Infections
- Antifungal resistance and susceptibility
- Pneumonia and Respiratory Infections
- Antifungal resistance and susceptibility
- Sepsis Diagnosis and Treatment
- Antibiotics Pharmacokinetics and Efficacy
- Fungal Infections and Studies
- Mycobacterium research and diagnosis
- COVID-19 Clinical Research Studies
- Mycobacterium research and diagnosis
- Pneumonia and Respiratory Infections
- Bacterial biofilms and quorum sensing
- Fungal Infections and Studies
- Bacterial biofilms and quorum sensing
- Fungal Infections and Studies
- Urinary Tract Infections Management
- Urinary Tract Infections Management
- Urinary Tract Infections Management
- Enterobacteriaceae and Cronobacter Research
- Salmonella and Campylobacter epidemiology
- COVID-19 Clinical Research Studies
- COVID-19 Clinical Research Studies
- Nosocomial Infections in ICU
- Infection Control in Healthcare
- SARS-CoV-2 and COVID-19 Research
- Pneumocystis jirovecii pneumonia detection and treatment
- Diagnosis and treatment of tuberculosis
- Diagnosis and treatment of tuberculosis
- Pneumocystis jirovecii pneumonia detection and treatment
- Mycobacterium research and diagnosis
- Bacterial Infections and Vaccines
- Infectious Diseases and Tuberculosis
- Infectious Diseases and Tuberculosis
- Neonatal and Maternal Infections
- Sepsis Diagnosis and Treatment
- Neonatal and Maternal Infections
- Streptococcal Infections and Treatments
- Streptococcal Infections and Treatments
- Escherichia coli research studies
- Microbial infections and disease research
- Sepsis Diagnosis and Treatment
- Escherichia coli research studies
- Escherichia coli research studies
- Actinomycetales infections and treatment
- Pharmaceutical and Antibiotic Environmental Impacts
- Bacterial biofilms and quorum sensing
- Pharmaceutical and Antibiotic Environmental Impacts
- Infections and bacterial resistance
- SARS-CoV-2 and COVID-19 Research
- SARS-CoV-2 and COVID-19 Research
- Infections and bacterial resistance
- Vibrio bacteria research studies
- Bacterial Infections and Vaccines
Keywords (DOAJ)
- bacterial infection
- viral infection
- fungal infection
- antibiotic resistance
- anti-infective drugs
- infection control
Community confirmations — what users saw in MJL or Scopus Sources; not platform verification and never part of any score.
The journal's record in other sources:Web of Science MJLDOAJ